Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN–PI3K–AKT axis

Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Orga...

Full description

Saved in:
Bibliographic Details
Published inBiochemistry and cell biology Vol. 99; no. 3; pp. 385 - 395
Main Authors Liu, Yupeng, Wu, Hui, Zhang, Fan, Yang, Jun, He, Jingchun
Format Journal Article
LanguageEnglish
Published 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7 NRC Research Press 01.05.2021
Canadian Science Publishing NRC Research Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K–Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN–PI3K–Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K–Akt signaling pathway to counteract cisplatin ototoxicity.
AbstractList Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN–PI3K–AKT signaling pathway. For this, House Ear Institute–Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K–Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN–PI3K–Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K–Akt signaling pathway to counteract cisplatin ototoxicity.
Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity.Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity.
Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the regulation of miR-455-5p by resveratrol on cisplatin-induced ototoxicity via the PTEN-PI3K-AKT signaling pathway. For this, House Ear Institute-Organ of Corti 1 (HEI-OC1) cells were transfected with miR-455-5p inhibitor and treated with cisplatin and resveratrol, then cell proliferation, apoptosis, and oxidative stress were evaluated. A mouse model of hearing loss was established, and these mice were treated with cisplatin, resveratrol, or cisplatin combined with resveratrol, by intraperitoneal injection. The auditory brainstem response (ABR) threshold was measured, and hair cells were examined using immunofluorescence staining. The expression levels of miR-455-5p, PTEN, and PI3K/Akt proteins were examined. The results from our in-vitro experiments indicate that resveratrol promoted viability and reduced apoptosis and oxidative stress in cisplatin-induced HEI-OC1 cells. Resveratrol upregulated miR-455-5p, downregulated PTEN, and activated the PI3K-Akt axis. These effects of resveratrol were reversed by knock-down of miR-455-5p. The results from our in-vivo experiments indicate that resveratrol protected hearing and inhibited the hair-cell injury caused by cisplatin ototoxicity. Resveratrol also upregulated miR-455-5p, downregulated PTEN, and activated the PTEN-PI3K-Akt axis in cochlear tissues from cisplatin-treated mice. These results indicate that resveratrol upregulates miR-455-5p to target PTEN and activate the PI3K-Akt signaling pathway to counteract cisplatin ototoxicity. Key words: resveratrol, cisplatin ototoxicity, miR-455-5p, PTEN, PI3K-Akt, oxidative stress. Le resvératrol est un composé polyphénolique non-flavonoïde présent dans de nombreuses plantes, et il est considéré comme une antitoxine végétale. Cette étude explore les effets du resvératrol régulant le miR-455-5p sur l'ototoxicité induite par le cisplatine par l'intermédiaire de la voie de signalisation PTEN-PI3K-AKT. DescellulesHEI-OC1 (House Ear Institute-Organ of Corti 1) ont été transfectées avec un inhibiteur du miR-455-5p et traitées avec du cisplatine et du resvératrol. La prolifération, l'apoptose et le stress oxydant ont été évalués chez les cellules HEI-OC1. Un modèle de souris avec perte auditive a été établi et les souris ont été traitées avec du cisplatine, du resvératrol ou du cisplatine combiné à du resvératrol par injection intrapéritonéale. Le seuil de réponse auditive du tronc cérébral (RAC) a été mesuré. Les cellules ciliées ont été examinées par coloration en immunofluorescence. L'expression du miR-455-5p, dePTEN et dePI3K-Akt a été détectée. Les résultats de l'expérience dans les celles ont indiqué que le resvératrol favorisait la viabilité et réduisait l'apoptose et le stress oxydant dans les cellules HEI-OC1 traitées au cisplatine. Le resvératrol régulait à la hausse le miR-455-5p, régulait à la baisse PTEN et activait l'axe PI3K-Akt. Ces effets du resvératrol étaient renversés par l'inhibition du miR-455-5p. Les résultats des expériences sur les animaux suggéraient que le resvératrol protégeait l'audition et inhibait les dommages aux cellules ciliées résultant de l'ototoxicité du cisplatine. Le resvératrol augmentait aussi l'expression du miR-455-5p, inhibait l'expression de PTEN et activait l'axe PTEN-PI3K-Akt des tissus de la cochlée chez les souris traitées au cisplatine. On pourrait conclure que le resvératrol augmente l'expression du miR-455-5p pour cibler PTEN et activer la voie de signalization PI3K/AKT pour antagoniser l'ototoxicité du cisplatine. [Traduit par la Rédaction] Mots-clés : resvératrol, ototoxicité du cisplatine, miR-455-5p, PTEN, PI3K-Akt, stress oxydant.
Abstract_FL Le resvératrol est un composé polyphénolique non-flavonoïde présent dans de nombreuses plantes, et il est considéré comme une antitoxine végétale. Cette étude explore les effets du resvératrol régulant le miR-455-5p sur l’ototoxicité induite par le cisplatine par l’intermédiaire de la voie de signalisation PTEN–PI3K–AKT. Des cellules HEI-OC1 (House Ear Institute–Organ of Corti 1) ont été transfectées avec un inhibiteur du miR-455-5p et traitées avec du cisplatine et du resvératrol. La prolifération, l’apoptose et le stress oxydant ont été évalués chez les cellules HEI-OC1. Un modèle de souris avec perte auditive a été établi et les souris ont été traitées avec du cisplatine, du resvératrol ou du cisplatine combiné à du resvératrol par injection intrapéritonéale. Le seuil de réponse auditive du tronc cérébral (RAC) a été mesuré. Les cellules ciliées ont été examinées par coloration en immunofluorescence. L’expression du miR-455-5p, de PTEN et de PI3K–Akt a été détectée. Les résultats de l’expérience dans les celles ont indiqué que le resvératrol favorisait la viabilité et réduisait l’apoptose et le stress oxydant dans les cellules HEI-OC1 traitées au cisplatine. Le resvératrol régulait à la hausse le miR-455-5p, régulait à la baisse PTEN et activait l’axe PI3K–Akt. Ces effets du resvératrol étaient renversés par l’inhibition du miR-455-5p. Les résultats des expériences sur les animaux suggéraient que le resvératrol protégeait l’audition et inhibait les dommages aux cellules ciliées résultant de l’ototoxicité du cisplatine. Le resvératrol augmentait aussi l’expression du miR-455-5p, inhibait l’expression de PTEN et activait l’axe PTEN–PI3K–Akt des tissus de la cochlée chez les souris traitées au cisplatine. On pourrait conclure que le resvératrol augmente l’expression du miR-455-5p pour cibler PTEN et activer la voie de signalization PI3K/AKT pour antagoniser l’ototoxicité du cisplatine. [Traduit par la Rédaction]
Audience Academic
Author Wu, Hui
Liu, Yupeng
He, Jingchun
Yang, Jun
Zhang, Fan
Author_xml – sequence: 1
  givenname: Yupeng
  surname: Liu
  fullname: Liu, Yupeng
  organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
– sequence: 2
  givenname: Hui
  surname: Wu
  fullname: Wu, Hui
  organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
– sequence: 3
  givenname: Fan
  surname: Zhang
  fullname: Zhang, Fan
  organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
– sequence: 4
  givenname: Jun
  surname: Yang
  fullname: Yang, Jun
  organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
– sequence: 5
  givenname: Jingchun
  surname: He
  fullname: He, Jingchun
  organization: Department of Otolaryngology-Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
BookMark eNqVks1u1DAUhSNUJKaFJXsLNrBw8U-ScZajqtBRq1INw9pynJvUVRKntlNNWfUdeEOeBIdBlEGDELqLK9nfObLvPYfJQW97SJKXlBxTyot3pS4xI4xgkmbFk2RGGRE4J4QdJDMiWIEFo_RZcuj9DSGUpYWYJcMK_B04FZxt0Tg4aMZWBfCoMyucZhnOBhQsUn1Qje3NF0Da-CEipkc2xNoYbcI9ujMKdbYaf9w0KFwDulqfXn57-Hq15OexLc7XSG2Mf548rVXr4cXPfpR8fn-6PjnDFx8_LE8WF1jnJAs4Lec1rVn8FklLxTgvVJmVPCeaQZlWtORQpEQIXkKhqrQq8mxecAE654pqzvlR8mbrOzh7O4IPsjNeQ9uqHuzoJct4LggpBI3o6z_QGzu6Pr4uUinlVNBs_kg1qgVp-toGp_RkKhf5nDEqGJm88B6qgT7OuI3rqk083uFf7eH1YG7l79DxHihWBZ3Re13f7ggiE2ATGjV6L5efVv_BXu6yfMtqZ713UMu4_LjxKHHKtJISOSVRxiTKKYlySuLjTH6pBmc65e7_ypMt3zvtwINy-vofku-6NO1O
CitedBy_id crossref_primary_10_3390_molecules28227614
crossref_primary_10_1080_17425255_2023_2260737
crossref_primary_10_3390_ijms23137227
crossref_primary_10_1016_j_intimp_2024_112464
crossref_primary_10_1177_10915818231206665
crossref_primary_10_3390_cancers15164187
crossref_primary_10_3390_ijms25084272
crossref_primary_10_3389_fnins_2023_1333131
crossref_primary_10_3390_ijms24087596
crossref_primary_10_1016_j_apsb_2023_11_001
crossref_primary_10_1007_s10555_023_10126_x
crossref_primary_10_3389_fphar_2024_1430469
crossref_primary_10_3389_fncel_2023_1197051
crossref_primary_10_3389_fphar_2022_910308
crossref_primary_10_1007_s10142_023_01173_2
crossref_primary_10_2174_0115672050272577231120060909
crossref_primary_10_3390_ani13030446
crossref_primary_10_1016_j_ecoenv_2022_113992
crossref_primary_10_1007_s11427_024_2803_1
crossref_primary_10_3389_fonc_2024_1453164
crossref_primary_10_3390_antiox13121578
crossref_primary_10_3390_medicina59112045
Cites_doi 10.1016/j.freeradbiomed.2019.03.019
10.1080/08923973.2019.1666406
10.1002/ar.22594
10.3892/ijmm.2020.4633
10.3390/ijms20205220
10.1044/2017_AJA-17-0074
10.1186/s12868-020-00588-y
10.1016/j.jtemb.2019.06.002
10.1016/j.jhazmat.2015.11.060
10.1111/1759-7714.12400
10.1007/s12264-018-0324-5
10.1039/D0FO00469C
10.1016/j.canlet.2019.03.043
10.1002/jcp.28755
10.1016/j.heares.2013.02.002
10.1016/j.mvr.2020.103988
10.1242/bio.016758
10.1007/s00405-019-05635-x
10.1159/000485312
10.1016/j.jinorgbio.2019.110699
10.1016/j.ijporl.2014.11.008
10.1016/j.heares.2015.04.002
10.1016/j.toxlet.2020.04.005
10.3390/molecules24071344
10.1016/j.toxlet.2015.06.012
10.3791/60299
10.3892/mmr.2019.9943
10.3389/fncel.2017.00137
10.1016/j.yexcr.2017.09.019
10.1038/s41419-018-0888-z
10.3390/nu11050946
10.1111/nyas.13422
10.3390/ijms20215423
10.3892/mmr.2020.11407
10.3892/mmr.2017.7912
10.1007/s10162-020-00759-y
10.22038/ijorl.2019.41914.2368
10.3390/molecules25010063
10.1002/cpt.1483
10.1155/2019/6595189
10.1111/j.1365-2990.2010.01076.x
10.1016/j.semcancer.2019.12.008
10.3390/ijms20184497
10.1016/j.neurobiolaging.2019.03.013
10.14715/cmb/2020.66.5.25
10.1016/j.tibs.2014.02.006
10.1016/j.saa.2019.117149
10.1016/j.taap.2018.06.010
10.3390/nu10111651
10.1038/cddis.2017.314
ContentType Journal Article
Copyright COPYRIGHT 2021 NRC Research Press
2021 Published by NRC Research Press
Copyright_xml – notice: COPYRIGHT 2021 NRC Research Press
– notice: 2021 Published by NRC Research Press
DBID AAYXX
CITATION
ISN
ISR
7QO
7QP
7QR
7TK
7TM
7U7
7U9
8FD
C1K
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1139/bcb-2020-0459
DatabaseName CrossRef
Gale In Context: Canada
Gale In Context: Science
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Biotechnology Research Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef



MEDLINE - Academic




Virology and AIDS Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1208-6002
EndPage 395
ExternalDocumentID A672218201
10_1139_bcb_2020_0459
bcb-2020-0459
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-~X
.55
.GJ
00T
0R~
23N
36B
3O-
4.4
53G
5GY
5RE
5RP
7X2
7X7
88E
88I
8AF
8AO
8CJ
8FE
8FG
8FH
8FI
8FJ
8FQ
8G5
A8Z
AAIKC
AAMNW
AAYJJ
ABDBF
ABEFU
ABJCF
ABJNI
ABUWG
ACGFO
ACGFS
ACGOD
ACIWK
ACPRK
ACSVP
ACUHS
ADBBV
AEUYN
AFKRA
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
APEBS
ATCPS
AZQEC
BBNVY
BCR
BCU
BEC
BENPR
BES
BGLVJ
BHPHI
BLC
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
D1I
D1J
D8U
DATHI
DWQXO
EAD
EAP
EBC
EBD
EBS
ECC
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
GUQSH
HCIFZ
HF~
HMCUK
HZ~
H~9
IAG
IAO
ICQ
IEA
IGS
IHR
INH
INR
IOF
IPNFZ
ISN
ISR
ITC
KB.
L7B
LK8
M0K
M1P
M2O
M2P
M2Q
M3C
M3G
M7P
MV1
MVM
NMEPN
NRXXU
NYCZX
O9-
ONR
OVD
P2P
PADUT
PDBOC
PEA
PHGZM
PHGZT
PQQKQ
PRG
PROAC
PSQYO
PV9
QF4
QM4
QN7
QO4
QRP
RIG
RRCRK
RRP
RZL
SJFOW
SV3
TEORI
TUS
UKHRP
VQG
WH7
X7M
ZAY
ZGI
ZXP
~KM
AAYXX
CITATION
PJZUB
PPXIY
PQGLB
7QO
7QP
7QR
7TK
7TM
7U7
7U9
8FD
C1K
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c605t-4b7f1f213904ba2339ab5b360c2eb4d1b3e940883be9ad4d9657938ec63a1c333
ISSN 0829-8211
1208-6002
IngestDate Sun Aug 24 03:24:32 EDT 2025
Wed Aug 13 06:35:31 EDT 2025
Wed Mar 19 01:01:48 EDT 2025
Thu Jun 12 23:24:06 EDT 2025
Tue Jun 10 15:32:27 EDT 2025
Tue Jun 10 20:23:15 EDT 2025
Fri Jun 27 03:49:53 EDT 2025
Fri Jun 27 05:10:46 EDT 2025
Thu Apr 24 23:05:09 EDT 2025
Tue Aug 05 12:05:18 EDT 2025
Fri Jun 13 18:33:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c605t-4b7f1f213904ba2339ab5b360c2eb4d1b3e940883be9ad4d9657938ec63a1c333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PQID 2541318157
PQPubID 47596
PageCount 11
ParticipantIDs gale_infotracgeneralonefile_A672218201
crossref_citationtrail_10_1139_bcb_2020_0459
gale_incontextgauss_ISR_A672218201
gale_infotraccpiq_672218201
gale_infotracacademiconefile_A672218201
crossref_primary_10_1139_bcb_2020_0459
proquest_miscellaneous_2536800981
gale_incontextgauss_ISN_A672218201
proquest_journals_2541318157
gale_infotracmisc_A672218201
nrcresearch_primary_10_1139_bcb_2020_0459
PublicationCentury 2000
PublicationDate 20210501
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 20210501
  day: 01
PublicationDecade 2020
PublicationPlace 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7
PublicationPlace_xml – name: 1840 Woodward Drive, Suite 1, Ottawa, ON K2C 0P7
– name: Ottawa
PublicationTitle Biochemistry and cell biology
PublicationYear 2021
Publisher NRC Research Press
Canadian Science Publishing NRC Research Press
Publisher_xml – name: NRC Research Press
– name: Canadian Science Publishing NRC Research Press
References refg40/ref40
refg18/ref18
refg22/ref22
refg36/ref36
refg11/ref11
refg25/ref25
refg6/ref6
refg15/ref15
refg29/ref29
refg43/ref43
refg26/ref26
refg14/ref14
refg5/ref5
refg37/ref37
refg19/ref19
refg21/ref21
refg7/ref7
refg4/ref4
refg46/ref46
refg48/ref48
refg10/ref10
refg1/ref1
refg32/ref32
refg35/ref35
refg42/ref42
refg24/ref24
refg16/ref16
refg50/ref50
refg13/ref13
refg27/ref27
refg20/ref20
refg38/ref38
refg45/ref45
refg49/ref49
refg31/ref31
refg9/ref9
refg34/ref34
refg8/ref8
refg2/ref2
refg23/ref23
refg17/ref17
refg30/ref30
refg12/ref12
refg28/ref28
refg41/ref41
refg39/ref39
refg3/ref3
Zhang B. (refg47/ref47) 2020; 66
refg44/ref44
refg33/ref33
References_xml – ident: refg37/ref37
  doi: 10.1016/j.freeradbiomed.2019.03.019
– ident: refg9/ref9
  doi: 10.1080/08923973.2019.1666406
– ident: refg1/ref1
  doi: 10.1002/ar.22594
– ident: refg6/ref6
  doi: 10.3892/ijmm.2020.4633
– ident: refg13/ref13
  doi: 10.3390/ijms20205220
– ident: refg32/ref32
  doi: 10.1044/2017_AJA-17-0074
– ident: refg46/ref46
  doi: 10.1186/s12868-020-00588-y
– ident: refg25/ref25
  doi: 10.1016/j.jtemb.2019.06.002
– ident: refg42/ref42
  doi: 10.1016/j.jhazmat.2015.11.060
– ident: refg43/ref43
  doi: 10.1111/1759-7714.12400
– ident: refg28/ref28
  doi: 10.1007/s12264-018-0324-5
– ident: refg48/ref48
  doi: 10.1039/D0FO00469C
– ident: refg50/ref50
  doi: 10.1016/j.canlet.2019.03.043
– ident: refg4/ref4
  doi: 10.1002/jcp.28755
– ident: refg41/ref41
  doi: 10.1016/j.heares.2013.02.002
– ident: refg30/ref30
  doi: 10.1016/j.mvr.2020.103988
– ident: refg14/ref14
  doi: 10.1242/bio.016758
– ident: refg39/ref39
  doi: 10.1007/s00405-019-05635-x
– ident: refg44/ref44
  doi: 10.1159/000485312
– ident: refg10/ref10
  doi: 10.1016/j.jinorgbio.2019.110699
– ident: refg22/ref22
  doi: 10.1016/j.ijporl.2014.11.008
– ident: refg19/ref19
  doi: 10.1016/j.heares.2015.04.002
– ident: refg49/ref49
  doi: 10.1016/j.toxlet.2020.04.005
– ident: refg23/ref23
  doi: 10.3390/molecules24071344
– ident: refg17/ref17
  doi: 10.1016/j.toxlet.2015.06.012
– ident: refg8/ref8
  doi: 10.3791/60299
– ident: refg24/ref24
  doi: 10.3892/mmr.2019.9943
– ident: refg15/ref15
  doi: 10.3389/fncel.2017.00137
– ident: refg26/ref26
  doi: 10.1016/j.yexcr.2017.09.019
– ident: refg20/ref20
  doi: 10.1038/s41419-018-0888-z
– ident: refg31/ref31
  doi: 10.3390/nu11050946
– ident: refg18/ref18
  doi: 10.1111/nyas.13422
– ident: refg35/ref35
  doi: 10.3390/ijms20215423
– ident: refg33/ref33
  doi: 10.3892/mmr.2020.11407
– ident: refg16/ref16
  doi: 10.3892/mmr.2017.7912
– ident: refg11/ref11
  doi: 10.1007/s10162-020-00759-y
– ident: refg36/ref36
  doi: 10.22038/ijorl.2019.41914.2368
– ident: refg5/ref5
  doi: 10.3390/molecules25010063
– ident: refg7/ref7
  doi: 10.1002/cpt.1483
– ident: refg29/ref29
  doi: 10.1155/2019/6595189
– ident: refg38/ref38
  doi: 10.1111/j.1365-2990.2010.01076.x
– ident: refg40/ref40
  doi: 10.1016/j.semcancer.2019.12.008
– ident: refg27/ref27
  doi: 10.3390/ijms20184497
– ident: refg45/ref45
  doi: 10.1016/j.neurobiolaging.2019.03.013
– volume: 66
  start-page: 142
  issue: 5
  year: 2020
  ident: refg47/ref47
  publication-title: Cell. Mol. Biol. (Noisy-le-grand).
  doi: 10.14715/cmb/2020.66.5.25
– ident: refg12/ref12
  doi: 10.1016/j.tibs.2014.02.006
– ident: refg34/ref34
  doi: 10.1016/j.saa.2019.117149
– ident: refg21/ref21
  doi: 10.1016/j.taap.2018.06.010
– ident: refg3/ref3
  doi: 10.3390/nu10111651
– ident: refg2/ref2
  doi: 10.1038/cddis.2017.314
SSID ssj0012498
Score 2.4355488
Snippet Resveratrol is a non-flavonoid polyphenol compound that exists in many plants, and is considered an antitoxin. This study explores the effects from the...
SourceID proquest
gale
crossref
nrcresearch
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 385
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Analysis
Antitoxins
Apoptosis
Brain stem
Cell injury
Cell proliferation
Chemotherapy
Cisplatin
cisplatin ototoxicity
Cochlea
Coloration
Flavonoids
Gene expression
Hair
Hair cells
Hearing
Hearing loss
Immunofluorescence
Injection
Kinases
MicroRNA
miR-455-5p
Organ of Corti
Ototoxicity
ototoxicité du cisplatine
Oxidative stress
Physiological aspects
PI3K–Akt
Properties
PTEN
PTEN protein
Resveratrol
resvératrol
Signal transduction
Signaling
stress oxydant
Title Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN–PI3K–AKT axis
URI http://www.nrcresearchpress.com/doi/abs/10.1139/bcb-2020-0459
https://www.proquest.com/docview/2541318157
https://www.proquest.com/docview/2536800981
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbGJgRcINhAjBVkEBpCI9DYSdpcdj9Vt6Fq6jZpXEW2645ILA1NMo1d8Q48CO_Ek3BO4qSJtvGnSmlqHzmpz5fjY-f4O4S8krY7mXSEY8kxcy3H1toSWuJymFbM8XhnLPMA2aE3OHb2TtyThYUftailLJXv1OW1-0r-R6tQBnrFXbL_oNmqUSiAc9AvHEHDcPwrHY90co6kyBhrnsWzIq28TjbOwpHluK7lxuhaQt-JU3h0L_WGCpMYg9_AR0zhcxEqdMLPQ4EZcfJEXmbz1MHRzrCMg-AHu3y_-gFO4Ya4CJPG2-AQ824VieOKjXK4Imj4naqQnzDL7X0WazNa4liQlw2y8MoCdn8O24-maC-L6osUzJ6HBJr9Z4ZpoTRYtTW24WirijJsxJ3kJpD5VpcZc6wLE83aXQvfJtZteJFkyWCV1wwyLxICmbGdFwk9rw4bHFlXpZIAL4bhroalvEHPPegdBgfb_eDD7nD_FlliMC8Bw7rU29ze7FcvrmA2mw_-5Y2XtK7cf99ovuEGGWfgXjRThuLp0xXXIPd3jh6Q-2aiQnsF6h6SBR0tk5VeJNLp2Ve6TvPQ4VzBy-T2Znl2Z6vEwQqJa_CkNXjSOTxpOqVzeNIKnrQGTwrwpHN4UoAnRXj-_PYdgQlfAEmKkHxEjvs7R1sDyyT4sBTMolPLkZ2JPWHQOW1HCsa5L6QruddWTEtnbEuufQeGQS61L8bO2PdcGE66Wnlc2Ipz_pgsRtNIP0HqAd3RbTb2HKUdwT1f-I6Q4E7r7sRrS3eVvC37O1CG_R6TsHwO8lkw9wNQT4DqCVA9q2S9Eo8L2pebBF-i8gKkUokwVutUZEkS7B4Og57XYXl-BPtGoVFD6LURmkzhzpQw-2Pg_yFFW0NyrSGp4vBLUKtdb9SeFvT11zXTaggCOlSj-k0Nj3_qhVaJ1sDYxyRgLjjIMIFwO6vkRVWNV8G4zkhPM5ThXhc5je2nv29ijdyd25UWWUxnmX4G04FUPjeP4C8JhQlk
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resveratrol+upregulates+miR-455-5p+to+antagonize+cisplatin+ototoxicity+via+modulating+the+PTEN%E2%80%93PI3K%E2%80%93AKT+axis&rft.jtitle=Biochemistry+and+cell+biology&rft.au=Liu%2C+Yupeng&rft.au=Wu%2C+Hui&rft.au=Zhang%2C+Fan&rft.au=Yang%2C+Jun&rft.date=2021-05-01&rft.pub=Canadian+Science+Publishing+NRC+Research+Press&rft.issn=0829-8211&rft.eissn=1208-6002&rft.volume=99&rft.issue=3&rft.spage=385&rft.epage=395&rft_id=info:doi/10.1139%2Fbcb-2020-0459&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0829-8211&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0829-8211&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0829-8211&client=summon